AIIMS Delhi has conducted India’s first dedicated clinical trial of an advanced brain stent for stroke treatment. The GRASSROOT trial, completed in 2025, evaluated the indigenous Supernova stent across multiple centres. The study proved safety and efficacy, leading to CDSCO approval and strengthening India’s medical device ecosystem. BulletsIn First India-only clinical trial for a stroke



